A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumors (Q33437948)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumors |
scientific article |
Statements
1 reference
A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumors (English)
1 reference
Elizabeth Cohen-Jonathan Moyal
1 reference
Vanesa Gregorc
1 reference
Paolo Andrea Zucali
1 reference
Jean Menard
1 reference
Ioana Kloos
1 reference
Jeff Hsu
1 reference
Ying Luan
1 reference
Emily Liu
1 reference
Remus Vezan
1 reference
Thorsten Graef
1 reference
Sofia Rivera
1 reference
24 December 2016
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference